Safety and effcacy of remimazolam tosilate for sedation during combined spinal-epidural anesthesia for orthopedic procedures: a randomized controlled trial
Authors:
Open Access
- 26 February 2024
- journal article
- research article
- Published by Springer Nature in BMC Anesthesiology
- Vol. 24 (1) , 1-9
Abstract
Objective: The objective of this study was to assess the efficacy and safety of Remimazolam in the context of combined spinal-epidural anesthesia for sedation during orthopedic surgery. Methods: This randomized controlled trial enrolled patients scheduled for orthopedic surgery under combined spinal-epidural anesthesia (N = 80), who were randomly allocated to receive either dexmedetomidine (Group-D) or remimazolam (Group-R). The target sedation range aimed for a Ramsay score of 2–5 or a BIS value of 60–80 to evaluate the effectiveness and safety of remimazolam during sedation. Results: The time taken to achieve the desired level of sedation was significantly shorter in the remimazolam group compared to the dexmedetomidine group (3.69 ± 0.75 vs. 9.59 ± 1.03; P < 0.0001). Patients in the remimazolam group exhibited quicker recovery, fewer intraoperative adverse events, more consistent vital signs, and greater satisfaction at various time points throughout the surgery. Conclusion: This preliminary study demonstrates that remimazolam tosilate serves as a safe and effective sedative for orthopedic surgery performed under combined spinal-epidural anesthesia, in comparison with dexmedetomidine.Keywords
Funding Information
- National Natural Science Foundation of China (81701891)
- the Natural Science Fund of Hubei Province in China (2022BCE007)
This publication has 25 references indexed in Scilit:
- Remimazolam - Can it become a cost-effective alternative to propofol for intravenous anesthesia and sedation?Journal of Clinical Anesthesia, 2022
- Effect of remimazolam versus propofol sedation on the quality of recovery after colonoscopyEuropean Journal of Anaesthesiology, 2022
- General Versus Neuraxial Anesthesia in Revision Surgery for Periprosthetic Joint InfectionThe Journal of Arthroplasty, 2022
- Remimazolam: A Review in Procedural SedationDrugs, 2021
- Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative reviewBritish Journal of Anaesthesia, 2021
- A Comparison of Neuraxial and General Anesthesia for Thirty-Day Postoperative Outcomes in United States Veterans Undergoing Total Knee ArthroplastyThe Journal of Arthroplasty, 2020
- Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During BronchoscopyChest, 2019
- Procedural sedation in the ICU and emergency departmentCurrent Opinion in Anaesthesiology, 2017
- Satisfaction and safety using dexmedetomidine or propofol sedation during endoscopic oesophageal proceduresEuropean Journal of Anaesthesiology, 2016
- A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopyGastrointestinal Endoscopy, 2016